Articles Tagged With:
-
Bamlanivimab Injection
Bamlanivimab is a neutralizing recombinant IgG1 monoclonal antibody that connects to the receptor-binding domain of the spike protein of SARS-CoV-2. The drug blocks attachment and entry of the virus into human cells.
-
When Aortic Stenosis Is Almost Severe: What Happens Next?
A study of patients with normal flow, low gradients, normal left ventricular systolic function but with calculated aortic valve areas <1.0 cm2 showed that about half of them progressed to severe aortic stenosis during the 25-month median follow-up period.
-
Rifampin vs. Isoniazid for Latent Tuberculosis
A health system cost comparison showed that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.
-
Rhythm vs. Rate Control for Atrial Fibrillation Patients: The Controversy Continues
Early use of rhythm control in patients with atrial fibrillation and high cardiovascular risk appears to improve cardiovascular outcomes compared to usual care.
-
Treating Hypertension Without Drugs
High flavanol intake was associated with lower blood pressure in men and women comparable to what is seen with a Mediterranean diet or moderate salt restriction.
-
An Anatomical Review of Trauma to the Mouth and Throat
Trauma to the mouth and throat is very common. Fortunately, the majority of the injuries are minor, but early and timely recognition of critical, potentially devastating injuries is essential. The authors provide a thorough review highlighting critical injuries and their management.
-
Will COVID-19 Establish an Animal Reservoir?
Minks farmed for their fur are acquiring SARS-CoV-2 from humans and transmitting it back, a classic scenario for a possible genetic mutation that could create a mismatch with some vaccines under development, the World Health Organization reported.
-
COVID-19 Inflammatory Syndrome Emerging in Adults
Healthcare workers could be at risk of multisystem inflammatory syndrome linked to COVID-19, as the poorly understood condition first seen in children now is emerging in adults.
-
15 Minutes of Infamy? CDC Warns of Cumulative Exposures
The Centers for Disease Control and Prevention raised questions after the agency said clinically significant COVID-19 close-contact exposures could occur in intervals over time.
-
With Political Change, OSHA Infectious Disease Standard Appears Back in Play
In acknowledged underestimates, the Centers for Disease Control and Prevention reports tens of thousands of healthcare workers have acquired COVID-19 and hundreds have died. With CDC guidelines nonregulatory, politicized, and too often ignored during the pandemic, the question arises: Could an enforceable infectious disease standard by the Occupational Safety and Health Administration have saved lives during the pandemic?